317
The European Medicines Agency has recommended that the antiviral remdesivir be used for the treatment of covid-19 disease in patients in very serious condition.
The indication for the use of the medicine used to combat Ebola is for adults and adolescents over 12 years of age with pneumonia and who are receiving oxygen. Even so, the final word on whether or not to use remdesivir will rest with the European Commission.
“Remdesivir is the first drug against Covid-19 to be recommended for authorization in the EU. The data on remdesivir has been evaluated in an exceptionally short period of time through a continuous review procedure, an approach used by EMA during public health emergencies to assess the data as it becomes available, ”writes the agency in a statement.
Read more in Jornal de Notícias
